ArticleFrontiers in pharmacology2018

Danshensu for Myocardial Ischemic Injury: Preclinical Evidence and Novel Methodology of Quality Assessment Tool.

Xiao-Yi Bao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.